Cancer Genetics, Inc. (NASDAQ: CGIX) is trading up over 6% in early trade after the company announced it has been ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE